RS1 and intrahepatic cholangiocarcinoma: Intravitreal gene therapy in RS1 knockout mice demonstrated long-term retinal morphology rescue and ICC resolution,12 while human trials using intravitreal application of adeno-associated virus for XLRS showed good safety profile but no morphological or functional improvements.13